SIMULTANEOUS ASSAY OF METFORMIN AND GLIBENCLAMIDE IN COMBINED DOSAGE FORM BY MEAN CENTERED OF SPECTRA RATIO METHODS | Zendy

Muchlisyam Bachri | Zendy; Exaudia Sitohang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

SIMULTANEOUS ASSAY OF METFORMIN AND GLIBENCLAMIDE IN COMBINED DOSAGE FORM BY MEAN CENTERED OF SPECTRA RATIO METHODS

Author(s) -

Muchlisyam Bachri,

Exaudia Sitohang

Publication year - 2019

Publication title -

rasayan journal of chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.281

H-Index - 22

eISSN - 0976-0083

pISSN - 0974-1496

DOI - 10.31788/rjc.2019.1235208

Subject(s) - glibenclamide , metformin , medicine , dosage form , pharmacology , chemistry , chromatography , endocrinology , diabetes mellitus

The Mean Centered of Spectra Ratio (MCSR) method is a practical and straight forward method to the determination of Metformin and Glibenclamide in tablet preparations using mathematical software models. The MCSR method has manipulated an absorption to amplitude and change the wavelength of Metformin from 235.6 nm to 244.4 nm and Glibenclamide from 228.2 nm to 210.3 nm. The method had met the requirements of method validation following ICH 2005. The statistical results showed that the levels were in accordance with the requirements of tablet preparations according to Indonesian Pharmacopoeia Edition V. The MCSR application had met the validation requirements for Metformin and Glibenclamide levels in tablet preparations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research